CirrusDx to market RT-PCR test for SARS-CoV-2

2020 03 18 20 13 7386 Virus Coronavirus Covid 19 400

CirrusDx will market a real-time reverse transcription polymerase chain reaction (RT-PCR) test that can detect SARS-CoV-2, which causes COVID-19.

The Allplex 2019-nCoV assay was developed by the South Korean-based company Seegene and given emergency use authorization (EUA) by the U.S. Food and Drug Administration (FDA).

The test simultaneously detects the genes N, E, and RdRP of SARS-CoV-2. It will be performed at CirrusDx's lab and results will be reported within 24 hours of sample receipt, according to the company.

Page 1 of 14
Next Page